Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      Kodiak Sciences Data at ARVO 2025 Highlight Power and Versatility of ABC Platform in Addressing Complex Multifactorial Ocular Diseases
      Biotech

      Kodiak Sciences Data at ARVO 2025 Highlight Power and Versatility of ABC Platform in Addressing Complex Multifactorial Ocular Diseases

      May 2, 2025
      Satsuma Pharmaceuticals Announces U.S. FDA Approval for Atzumi™ (Dihydroergotamine) Nasal Powder for the Acute Treatment of Migraine
      Biotech

      Satsuma Pharmaceuticals Announces U.S. FDA Approval for Atzumi™ (Dihydroergotamine) Nasal Powder for the Acute Treatment of Migraine

      May 1, 2025
      S&E bio Receives Korea’s First Approval for Exosome-Based Therapy Clinical Trial
      Biotech

      S&E bio Receives Korea’s First Approval for Exosome-Based Therapy Clinical Trial

      May 1, 2025
      Innovent Announces First Patient Dosed in Phase 1 Study of IBI3020, Global First-in-class Dual Payload CEACAM5 ADC,  in Patients with Advanced Malignancies
      Biotech

      Innovent Announces First Patient Dosed in Phase 1 Study of IBI3020, Global First-in-class Dual Payload CEACAM5 ADC, in Patients with Advanced Malignancies

      April 30, 2025
      Genocury Biotech Annouces Groundbreaking Advance in Relapsed/Refractory DLBCL Through Pioneering In Vivo CD19 CAR-T Therapy
      Biotech

      Genocury Biotech Annouces Groundbreaking Advance in Relapsed/Refractory DLBCL Through Pioneering In Vivo CD19 CAR-T Therapy

      April 30, 2025
      Domain Therapeutics Presents Novel Data Addressing Key Challenges in Oncology at AACR 2025
      Biotech

      Domain Therapeutics Presents Novel Data Addressing Key Challenges in Oncology at AACR 2025

      April 30, 2025
      Sobi publishes Q1 2025 report: Portfolio continues to deliver
      Biotech

      Sobi publishes Q1 2025 report: Portfolio continues to deliver

      April 29, 2025
      Quarterly report Q1/2025: Enzymatica strengthens its position in home markets and focuses on international expansion
      Biotech

      Quarterly report Q1/2025: Enzymatica strengthens its position in home markets and focuses on international expansion

      April 29, 2025
      Stealth BioTherapeutics Announces Delay in FDA Action Date for  Barth Syndrome Application
      Biotech

      Stealth BioTherapeutics Announces Delay in FDA Action Date for Barth Syndrome Application

      April 29, 2025
      Comac Medical Announces New Leadership Appointments and International Expansion
      Biotech

      Comac Medical Announces New Leadership Appointments and International Expansion

      April 28, 2025
      « 1 … 33 34 35 36 37 … 140 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026